Tony Bark@pawb.social to science@lemmy.worldEnglish · edit-21 year agoScientists discover how to reactivate cancer’s molecular “kill switch” at the Jackson Laboratorywww.jax.orgexternal-linkmessage-square6linkfedilinkarrow-up1152arrow-down13
arrow-up1149arrow-down1external-linkScientists discover how to reactivate cancer’s molecular “kill switch” at the Jackson Laboratorywww.jax.orgTony Bark@pawb.social to science@lemmy.worldEnglish · edit-21 year agomessage-square6linkfedilink
minus-squareMaeve@kbin.earthlinkfedilinkarrow-up18·1 year agoWill it be accessible to everyone? I read it. Just musing.
minus-squareScolding7300@lemmy.worldlinkfedilinkEnglisharrow-up8·edit-23 months agodeleted by creator
minus-squareDharma Curious (he/him)@slrpnk.netlinkfedilinkEnglisharrow-up7·1 year agoProbably not in the US, but hopefully it’ll at least be accessible for the insured…
minus-squareearphone843@sh.itjust.workslinkfedilinkEnglisharrow-up4·1 year agoIt really depends on if production can scale.
minus-squareTony Bark@pawb.socialOPlinkfedilinkEnglisharrow-up2·1 year agoI hope so. It is RNA-based.
minus-squareGentriFriedRice@lemmy.worldlinkfedilinkEnglisharrow-up3·1 year agoWell the RNA bit is the easy part. Finding a way to target cancer cells with gene splicing gets trickier
Will it be accessible to everyone? I read it. Just musing.
deleted by creator
Probably not in the US, but hopefully it’ll at least be accessible for the insured…
It really depends on if production can scale.
I hope so. It is RNA-based.
Well the RNA bit is the easy part. Finding a way to target cancer cells with gene splicing gets trickier